Press Release - Akadeum and Agilent Team Up to Explore New Testing Workflow
Akadeum and Agilent Team Up to Explore New Testing Workflow
Novel Akadeum microbubble technology can be the answer to improved quality and reduced costs across multiple fields of testing.
October 30, 2019, Ann Arbor, MI – Akadeum Life Sciences, Inc., an Ann Arbor-based biotechnology company, announced today that it has entered into a collaboration with Agilent Technologies, Inc. to work toward a new method of isolating target molecules for detection. Akadeum aims to disrupt the status quo in isolation technology with their buoyant microbubbles. Notably, Akadeum is the first company to commercialize buoyancy-based cell isolation with their growing portfolio of human and mouse cell enrichment kits for immunology researchers. In addition, the same technology can be leveraged to improve isolation workflows and capabilities for target molecules such as DNA, protein, microbes, and others; which, Akadeum is developing through strategic partnerships.
“Sample preparation is a critical, yet often undervalued, step in most analytical assays. Often, the task of sample preparation employs decades old technology that is manual, time-consuming, and resource-intensive," said Brandon McNaughton, CEO of Akadeum Life Sciences. “Akadeum was founded to bring simple and superior isolation solutions to a variety of industries through our buoyancy-based microbubble technology and we are excited to be starting work with Agilent to explore new applications.”
Agilent, an early investor in Akadeum, has engaged in this collaboration with the shared goal of using Akadeum microbubbles to improve upon current analytical workflows. “The Akadeum technology has real promise to be a disruptive force in customers’ sample preparation workflows. We’re excited to test whether the simplicity of the solution drives downtime and cost requirements in customer environments,” said Michael Linderman, Vice President Business Development at Agilent.
To learn more about Akadeum microbubbles, investment, or partnerships, visit https://www.akadeum.com.
Akadeum Life Sciences, Inc. was established to create the next generation isolation technology and to fundamentally change the way that isolating cells and other targets is approached. The company is using microbubbles to solve longstanding problems in the industry. Isolation applications include research, in vitro diagnostics, pathogen detection and cell therapy. The company is located in Ann Arbor, MI. Inquiries into Akadeum’s products or technology can be made at firstname.lastname@example.org or https://www.akadeum.com/.
Contact: Michael Maloney, Director of Marketing & Business Development, email@example.com